NNRTIs DECREASE HIV-1 PRODUCTION FROM RCD4+ T CELLS FOLLOWING LATENCY REVERSAL
Background: Therapeutic strategies which target the latent HIV-1 reservoir in resting CD4+ T cells of infected-individuals are always administered in the presence of combination antiretroviral (ART) therapy. In this study, we evaluated whether the different therapeutic classes of ARV drugs impacted HIV-1 latency reversal. Methods: Latency reversal was evaluated in a primary cell model of…